Go to Client Portal

Tracy Murphy, BS

Senior Project Manager, IVD

Reserve your Consultation with our Experts

Contact Us

Tracy has been in the biotechnology industry for 18 years with more than 10 years focused on In Vitro Diagnostics (IVDs). She is experienced in manufacturing, quality control (QC)/ quality assurance (QA) and product development for IVDs, with a particular focus on immunoassays and cell-based assays.

Tracy joined NAMSA in 2021. Prior to joining NAMSA, she worked at ImmunoChemistry Technologies for more than a decade in various roles, most recently as Director of R&D and QC, where she managed product development and commercialization for a large portfolio.

Tracy holds a BSc in cell biology from the University of Minnesota, Duluth.


  • Project management and cross-functional leadership for the clinical, regulatory and reimbursement teams ensuring accurate and timeline project completion
  • Proposal development and quoting of NAMSA support, as well as ensuring accuracy and timely delivery of proposals to customers
  • Experienced in IVD assay and product development in areas such as immunoassays and cell-based assays 


  • IVDR Technical File Support for 14 Hematology Products
    • Gap assessments, literature searches and full Technical File development for 14 devices to help sponsor prepare to obtain regulatory compliance with the Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on IVD medical devices (EU-IVDR 2017/746) for devices with a current CE Certificate on their systems and reagents
  • COVID-19 EUA Point-of-Care Clinical Study
    • EUA clinical study support for Rapid Molecular COVID-19 test in a Point-of-Care/Clinical Laboratory Improvement Amendments (CLIA)-waived setting—support included protocol, site support (identification, qualification, contract/budget negotiation, initiation and subject Informed Consent Form [ICF] verification), statistics, data management and clinical study report writing
  • Reimbursement Consulting for Whole Blood Point-of-Care Coagulation Assay
    • Broad-scope reimbursement consulting, including the following reports and presentations: Reimbursement Landscape, Payer Perspective Analysis, Private Payer Research and Qualitative Claims Map